Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Message to Shareholders

<< Previous

Bullboard Posts

Next >>

Comment by wizzdumbon May 12, 2022 8:28pm

132 Views

Post# 34679971

RE:RE:Message to Shareholders

Cameron is the real deal. He is focusing on what is under their control, which is all they can do. The expansion will be complete soon, and the rubber will hit the road on the way to "unprecedented financial results"

Stay the course, reap the rewards

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec